Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

To Evaluate the Dose Response of 3 Doses of Euphorbia Prostrata in Patients With First and Second Degree Hemorrhoids

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Panacea Biotec Ltd
ClinicalTrials.gov Identifier:
NCT01041911
First received: December 31, 2009
Last updated: December 4, 2012
Last verified: December 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2010
  Primary Completion Date: October 2010 (Final data collection date for primary outcome measure)